Medical Guidelines Group in the UK says that sperm washing is no safer than effective treatment and timed intercourse
May 24, 2012
HIV Cure Related Studies Currently Enrolling
May 30, 2012

Global Health Needs Extend Beyond HIV/AIDS R&D

By Mari Serebrov
Washington Editor

A singular focus on HIV/AIDS and a lag in translating
medical discoveries into approvable medicines could be
keeping the U.S. from getting its money’s worth from R&D
aimed at addressing the most pressing global health needs.
While the U.S. government is the leading funder of R&D
for 26 of the 30 most neglected diseases and conditions
affecting the developing world, nearly 60 percent of the $1 .4
billion the U.S. invests annually in global R&D is dedicated to
HIV/AIDS research, according to a recent report from PATH’s
Global Health Technologies Coalition.
The next biggest chunk of U.S. funding, 12 percent, is
spent on tuberculosis (TB) R&D, and 10 percent goes for
malaria R&D. The rest is divided among other diseases and
conditions, such as dengue fever, that affl ict many parts of
the developing world.

Nelson Vergel
Nelson Vergel
Chemical engineer, 34+ year HIV and cancer survivor, health author and educator . Founder of , , and

Comments are closed.